1. Home
  2. HBM vs NUVL Comparison

HBM vs NUVL Comparison

Compare HBM & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudbay Minerals Inc. (Canada)

HBM

Hudbay Minerals Inc. (Canada)

HOLD

Current Price

$25.74

Market Cap

7.2B

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$108.17

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBM
NUVL
Founded
1927
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.3B
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
HBM
NUVL
Price
$25.74
$108.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
16
Target Price
$25.00
$134.75
AVG Volume (30 Days)
5.0M
563.6K
Earning Date
05-01-2026
05-07-2026
Dividend Yield
0.06%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$30.66
N/A
Revenue Next Year
$14.54
$1,235.73
P/E Ratio
$21.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.98
$63.56
52 Week High
$28.74
$113.02

Technical Indicators

Market Signals
Indicator
HBM
NUVL
Relative Strength Index (RSI) 65.33 64.21
Support Level $23.27 $97.94
Resistance Level $28.64 $112.61
Average True Range (ATR) 0.90 3.65
MACD 0.55 0.63
Stochastic Oscillator 90.13 98.02

Price Performance

Historical Comparison
HBM
NUVL

About HBM Hudbay Minerals Inc. (Canada)

Hudbay Minerals Inc is a copper-focused critical minerals company with three long-life operations and a pipeline of copper growth projects in Canada, Peru, and the United States. Its operating portfolio includes the Constancia mine in Cusco (Peru), the Snow Lake operations in Manitoba (Canada), and the Copper Mountain mine in British Columbia (Canada). Copper is the primary metal produced by the company, which is complemented by gold, zinc, silver, and molybdenum production. Hudbay's growth pipeline includes the Copper World project and the Mason project in the USA, and the Llaguen project in Peru. The company's reportable segments are: Peru, which generates the maximum revenue, Manitoba, British Columbia, and Arizona. Geographically, it generates maximum revenue from China and Canada.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: